LAMISIL Side Effects

6663197-9 | Angina Pectoris, C-reactive Protein Increased, Cytolytic Hepatitis, Endotracheal Intubation, Epidermolysis, Lymphadenopathy, Malaise, Mucosal Erosion
on Mar 22, 2010 Female patient from FRANCE , 16 years of age, weighting 132.3 lb, was diagnosed with onychomycosis, epilepsy (What is epilepsy?) and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, c-reactive protein increased, cytolytic hepatitis, endotracheal intubation, epidermolysis, lymphadenopathy, malaise, mucosal erosion. Lamisil dosage: Unk. During the same period patient was treated with LAMICTAL CD (Unk) (View Lamictal Cd Review and Lamictal Cd Label ). Patient was hospitalized.

6661320-3 | Abdominal Discomfort, Muscle Twitching, Photophobia, Photopsia, Retinal Haemorrhage, Vision Blurred
Patient was taking Lamisil (View Usage). Patient had the following side effects: abdominal discomfort, muscle twitching, photophobia, photopsia, retinal haemorrhage, vision blurred on Mar 19, 2010 from CANADA Additional patient health information: Male patient , 59 years of age, . Lamisil dosage: Unk. During the same period patient was treated with ROBAXACET (Unk) (View Robaxacet Review and Robaxacet Label ).

6656032-6 | Infarction
Adverse event was reported on Mar 19, 2010 by a Male patient taking Lamisil (View Usage) (Dosage: 250 Mg (1 Tablet) Per Day) was diagnosed with onychomycosis and. Location: MEXICO , 74 years of age, After Lamisil was administered, patient had the following side effects: infarction.

6655970-8 | Acute Myocardial Infarction, Blood Creatinine Increased, Bradycardia, Cardiac Pacemaker Insertion, Cardiogenic Shock, Chest Discomfort, Circulatory Collapse, Clostridial Infection, Continuous Haemodiafiltration
on Mar 24, 2010 Male patient from JAPAN , weighting 132.3 lb, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, blood creatinine increased, bradycardia, cardiac pacemaker insertion, cardiogenic shock, chest discomfort, circulatory collapse, clostridial infection, continuous haemodiafiltration. Lamisil dosage: 125 Mg Daily. During the same period patient was treated with KINEDAK (View Kinedak Review and Kinedak Label ), ZANTAC (View Zantac Review and Zantac Label ), ALOSENN (View Alosenn Review and Alosenn Label ), SHAKUYAKUKANZOUTOU (View Shakuyakukanzoutou Review and Shakuyakukanzoutou Label ). Patient was hospitalized.


6650300-X | Angina Pectoris, Epidermolysis, Lymphadenopathy, Mucosal Erosion, Oropharyngeal Pain, Pyrexia, Rash Papular, Toxic Epidermal Necrolysis
on Mar 15, 2010 Female patient from FRANCE , 16 years of age, was diagnosed with onychomycosis, epilepsy (What is epilepsy?) and was treated with Lamisil (View Usage). Patient had the following side effects: angina pectoris, epidermolysis, lymphadenopathy, mucosal erosion, oropharyngeal pain, pyrexia, rash papular, toxic epidermal necrolysis. Lamisil dosage: Unk. During the same period patient was treated with LAMICTAL CD (View Lamictal Cd Review and Lamictal Cd Label ). Patient was hospitalized.

6645958-5 | Infarction
Patient was taking Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: infarction on Mar 19, 2010 from MEXICO Additional patient health information: Male patient , 59 years of age, . Lamisil dosage: 1 Tablet Per Day.

6644188-0 | Acute Myocardial Infarction, Blood Creatinine Increased, Bradycardia, Cardiac Pacemaker Insertion, Cardiogenic Shock, Chest Discomfort, Circulatory Collapse, Clostridial Infection, Continuous Haemodiafiltration
Adverse event was reported on Mar 18, 2010 by a Male patient taking Lamisil (View Usage) (Dosage: 125 Mg/day) . Location: JAPAN , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, blood creatinine increased, bradycardia, cardiac pacemaker insertion, cardiogenic shock, chest discomfort, circulatory collapse, clostridial infection, continuous haemodiafiltration. During the same period patient was treated with KINEDAK (View Kinedak Review and Kinedak Label ), ZANTAC (View Zantac Review and Zantac Label ), ALOSENN (View Alosenn Review and Alosenn Label ), SHAKUYAKUKANZOUTOU (View Shakuyakukanzoutou Review and Shakuyakukanzoutou Label ). Patient was hospitalized.

6638432-3 | Coagulopathy, Dialysis, Headache, Jaundice, Malaise, Mental Status Changes, Nausea, Pyrexia, Renal Failure Acute
on Mar 16, 2010 Male patient from UNITED STATES , 46 years of age, weighting 238.1 lb, was treated with Lamisil (View Usage). Patient had the following side effects: coagulopathy, dialysis (What is dialysis?), headache (What is headache?), jaundice (What is jaundice?), malaise, mental status changes, nausea (What is nausea?), pyrexia, renal failure acute. Lamisil dosage: 250 Mg Daily Oral 047. Patient was hospitalized.

6627722-6 | Blood Glucose Abnormal, Hyperkeratosis, Infection, Toe Amputation
on Mar 01, 2010 Male patient from MEXICO , 62 years of age, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: blood glucose abnormal, hyperkeratosis, infection (What is infection?), toe amputation. Lamisil dosage: 1 Tablet Per Day. During the same period patient was treated with INSULIN (Unk) (View Insulin Review and Insulin Label ). Patient was hospitalized.

6616437-6 | Acute Myocardial Infarction, Blood Creatinine Increased, Bradycardia, Cardiac Pacemaker Insertion, Cardiogenic Shock, Chest Discomfort, Circulatory Collapse, Clostridial Infection, Continuous Haemodiafiltration
Patient was taking Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, blood creatinine increased, bradycardia, cardiac pacemaker insertion, cardiogenic shock, chest discomfort, circulatory collapse, clostridial infection, continuous haemodiafiltration on Feb 24, 2010 from JAPAN Additional patient health information: Male patient , weighting 132.3 lb, . Lamisil dosage: 125 Mg/day. During the same period patient was treated with KINEDAK (View Kinedak Review and Kinedak Label ), ZANTAC (View Zantac Review and Zantac Label ), ALOSENN (View Alosenn Review and Alosenn Label ), SHAKUYAKUKANZOUTOU (View Shakuyakukanzoutou Review and Shakuyakukanzoutou Label ). Patient was hospitalized.

6613279-2 | Face Oedema, Focal Segmental Glomerulosclerosis, Glomerulonephritis Membranous, Hyperlipidaemia, Hypoproteinaemia, Nephrotic Syndrome, Oedema Peripheral, Pleural Effusion, Proteinuria
Adverse event was reported on Feb 17, 2010 by a Female patient taking Lamisil (View Usage) (Dosage: 125 Mg Daily) was diagnosed with collagen disorder and. Location: JAPAN , weighting 83.78 lb, Patient had the following side effects: face oedema, focal segmental glomerulosclerosis, glomerulonephritis membranous, hyperlipidaemia, hypoproteinaemia, nephrotic syndrome, oedema peripheral, pleural effusion, proteinuria. During the same period patient was treated with OPALMON (10 Ug, Unk) (View Opalmon Review and Opalmon Label ), PREDONINE (5 Mg) (View Predonine Review and Predonine Label ), SELBEX (100 Mg, Unk) (View Selbex Review and Selbex Label ). Patient was hospitalized.

6608986-1 | Abdominal Pain, Coagulopathy, Jaundice, Liver Transplant, Malaise, Mental Status Changes
on Feb 26, 2010 Female patient from UNITED STATES , 39 years of age, weighting 176.4 lb, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), coagulopathy, jaundice (What is jaundice?), liver transplant (What is liver transplant?), malaise, mental status changes. Lamisil dosage: 250 Mg Daily Oral 047. Patient was hospitalized.

6589963-6 | Face Oedema, Focal Segmental Glomerulosclerosis, Oedema Peripheral, Pleural Effusion, Protein Urine
on Feb 05, 2010 Female patient from JAPAN , 39 years of age, was diagnosed with collagen disorder and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, focal segmental glomerulosclerosis, oedema peripheral, pleural effusion, protein urine. Lamisil dosage: 125 Mg Daily. During the same period patient was treated with OPALMON (10 Microgram) (View Opalmon Review and Opalmon Label ), PREDONINE (5 Mg) (View Predonine Review and Predonine Label ), SELBEX (View Selbex Review and Selbex Label ). Patient was hospitalized.

6581714-4 | Abdominal Discomfort, Muscle Twitching, Photophobia, Photopsia, Retinal Haemorrhage, Vision Blurred
Patient was taking Lamisil (View Usage). Patient had the following side effects: abdominal discomfort, muscle twitching, photophobia, photopsia, retinal haemorrhage, vision blurred on Feb 01, 2010 from CANADA Additional patient health information: Male patient , 59 years of age, . Lamisil dosage: Unk.

6580348-5 | Blood Lactate Dehydrogenase Increased, Lymphocyte Count Increased, Neutrophil Count Decreased
Adverse event was reported on Feb 01, 2010 by a Female patient taking Lamisil (View Usage) (Dosage: 125 Mg, Unk) . Location: JAPAN , 71 years of age, After Lamisil was administered, patient had the following side effects: blood lactate dehydrogenase increased, lymphocyte count increased, neutrophil count decreased.

6577299-9 | Asthenia, Lethargy, Neutrophil Count Decreased, White Blood Cell Count Decreased
on Jan 04, 2010 Male patient from UNITED KINGDOM , 79 years of age, was diagnosed with onychomycosis, pain (What is pain?), abdominal pain (What is abdominal pain?) and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, lethargy, neutrophil count decreased, white blood cell count decreased. Lamisil dosage: 250 Mg, Unk. During the same period patient was treated with ADALAT (90 Mg, Qd) (View Adalat Review and Adalat Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), CARMELLOSE (1 %, Bid) (View Carmellose Review and Carmellose Label ), CO CODAMOL (Prn) (View Co-codamol Review and Co-codamol Label ), FLUNISOLIDE (25 Ug, Unk) (View Flunisolide Review and Flunisolide Label ), GLYCERYL TRINITRATE (300 Ug, Unk) (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ), MEBEVERINE (135 Mg, Prn) (View Mebeverine Review and Mebeverine Label ), NITRAZEPAM (5 Mg, Qd) (View Nitrazepam Review and Nitrazepam Label ).

6576024-5 | Abdominal Pain, Anaphylactic Reaction, Depressed Level Of Consciousness, Immobile, Lethargy, Unresponsive To Stimuli
on Jan 27, 2010 Male patient from BARBADOS , child 8 years of age, was diagnosed with tinea capitis and was treated with Lamisil (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anaphylactic reaction, depressed level of consciousness, immobile, lethargy, unresponsive to stimuli. Lamisil dosage: 125 Mg Daily.

6574946-2 | Haematemesis, Haemoptysis, Pulmonary Haemorrhage, Surgery
Patient was taking Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: haematemesis, haemoptysis, pulmonary haemorrhage, surgery (What is surgery?) on Feb 02, 2010 from JAPAN Additional patient health information: Male patient , 64 years of age, . Lamisil dosage: 125 Mg, Per Day. During the same period patient was treated with LORCAM (Unk) (View Lorcam Review and Lorcam Label ), EPENARD (Unk) (View Epenard Review and Epenard Label ), CHANTIX (Unk) (View Chantix Review and Chantix Label ). Patient was hospitalized.

6568723-6 | Haematemesis, Pulmonary Haemorrhage, Surgery
Adverse event was reported on Jan 28, 2010 by a Male patient taking Lamisil (View Usage) (Dosage: 125 Mg, Unk) . Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: haematemesis, pulmonary haemorrhage, surgery (What is surgery?). Patient was hospitalized.

6567903-3 | Liver Disorder
on Jan 25, 2010 Male patient from JAPAN , 67 years of age, was treated with Lamisil (View Usage). Patient had the following side effects: liver disorder. Lamisil dosage: 125 Mg Daily.

6567376-0 | Acute Myeloid Leukaemia, Arthralgia, Blood Count Abnormal, Bronchitis, Chills, Cough, Dyspnoea, Epicondylitis
on Jan 27, 2010 Male patient from UNITED STATES , weighting 170.0 lb, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: acute myeloid leukaemia, arthralgia, blood count abnormal, bronchitis (What is bronchitis?), chills, cough, dyspnoea, epicondylitis. Lamisil dosage: Unk.

6567339-5 | Fall, Hip Fracture
Patient was taking Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hip fracture on Jan 23, 2010 from MEXICO Additional patient health information: Male patient , 52 years of age, was diagnosed with onychomycosis and. Lamisil dosage: 250 Mg/day. Patient was hospitalized.

6534094-4 | Focal Segmental Glomerulosclerosis
Adverse event was reported on Jan 06, 2010 by a Female patient taking Lamisil (View Usage) (Dosage: Unk) . Location: JAPAN , 39 years of age, Patient had the following side effects: focal segmental glomerulosclerosis. During the same period patient was treated with OPALMON (View Opalmon Review and Opalmon Label ), PREDONINE (View Predonine Review and Predonine Label ), SELBEX (View Selbex Review and Selbex Label ). Patient was hospitalized.

6532996-6 | Asthenia, Lethargy, White Blood Cell Count Decreased
on Jan 04, 2010 Male patient from UNITED KINGDOM , 79 years of age, was diagnosed with onychomycosis, pain (What is pain?), abdominal pain (What is abdominal pain?) and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: asthenia, lethargy, white blood cell count decreased. Lamisil dosage: 250 Mg, Unk. During the same period patient was treated with ADALAT (90 Mg, Qd) (View Adalat Review and Adalat Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), CARMELLOSE (1 %, Bid) (View Carmellose Review and Carmellose Label ), CO CODAMOL (Prn) (View Co-codamol Review and Co-codamol Label ), FLUNISOLIDE (25 Ug, Unk) (View Flunisolide Review and Flunisolide Label ), GLYCERYL TRINITRATE (300 Ug, Unk) (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ), MEBEVERINE (135 Mg, Prn) (View Mebeverine Review and Mebeverine Label ), NITRAZEPAM (5 Mg, Qd) (View Nitrazepam Review and Nitrazepam Label ).

6529318-3 | Epilepsy
on Dec 29, 2009 Male patient from FRANCE , weighting 231.5 lb, was diagnosed with epilepsy (What is epilepsy?), hypercholesterolaemia and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?). Lamisil dosage: 250 Mg, Bid. During the same period patient was treated with LAMICTAL (200 Mg, Bid) (View Lamictal Review and Lamictal Label ), FENOFIBRATE (145 Mg, Unk) (View Fenofibrate Review and Fenofibrate Label ), URBANYL (Unk) (View Urbanyl Review and Urbanyl Label ).

6528289-3 | Diarrhoea, Tumour Marker Increased
Patient was taking Lamisil (View Usage). Patient had the following side effects: diarrhoea, tumour marker increased on Dec 25, 2009 from JAPAN Additional patient health information: Female patient , 60 years of age, . Lamisil dosage: Unk.

6526871-0 | Blood Glucose Increased
Adverse event was reported on Dec 22, 2009 by a Male patient taking Lamisil (View Usage) (Dosage: 125 Mg) . Location: JAPAN , 50 years of age, After Lamisil was administered, patient had the following side effects: blood glucose increased. During the same period patient was treated with ANTIHYPERTENSIVES (Unk) (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.

6526853-9 | Hyperkeratosis, Infection, Toe Amputation
on Dec 22, 2009 Male patient from MEXICO , 62 years of age, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkeratosis, infection (What is infection?), toe amputation. Lamisil dosage: 1 Tablet Per Day. During the same period patient was treated with INSULIN (Unk) (View Insulin Review and Insulin Label ). Patient was hospitalized.

6526808-4 | Hepatitis Cholestatic
on Jan 04, 2010 Male patient from UNITED STATES , 43 years of age, weighting 174.0 lb, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). Patient had the following side effects: hepatitis cholestatic. Lamisil dosage: 250 Mg Once Daily Oral. During the same period patient was treated with BENICAR (View Benicar Review and Benicar Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ).

6523507-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Feeling Cold, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Tremor
Patient was taking Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, feeling cold, gamma-glutamyltransferase increased, hepatic function abnormal, tremor on Dec 19, 2009 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with tinea infection (What is tinea infection?), cardiac disorder and. Lamisil dosage: 125 Mg, Unk. During the same period patient was treated with BERAPROST SODIUM (View Beraprost Sodium Review and Beraprost Sodium Label ), ETHYL ICOSAPENTATE (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ).

6520097-2 | Abdominal Pain, Anaphylactic Reaction, Lethargy, Unresponsive To Stimuli
Adverse event was reported on Dec 23, 2009 by a Male patient taking Lamisil (View Usage) (Dosage: 125 Mg, Unk) was diagnosed with tinea capitis and. Location: BARBADOS , child 8 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anaphylactic reaction, lethargy, unresponsive to stimuli.

6520085-6 | Pain, Pruritus, Pyrexia, Rash, Rash Erythematous, Rash Morbilliform, Rash Pruritic
on Dec 17, 2009 Female patient from FRANCE , 17 years of age, was diagnosed with muscle strain, pharyngitis, fungal infection (What is fungal infection?) and was treated with Lamisil (View Usage). Patient had the following side effects: pain (What is pain?), pruritus, pyrexia, rash (What is rash?), rash erythematous, rash morbilliform, rash pruritic. Lamisil dosage: 250 Mg, Unk. During the same period patient was treated with LAMOTRIGINE (50 Mg, No Treatment) (View Lamotrigine Review and Lamotrigine Label ), IBUPROFEN (2-3 Df) (View Ibuprofen Review and Ibuprofen Label ), AMOXICILLIN (2 Df, Daily) (View Amoxicillin Review and Amoxicillin Label ), PEVARYL (1-2 Application Daily) (View Pevaryl Review and Pevaryl Label ). Patient was hospitalized.

6509944-8 | Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Body Temperature Increased, Cytomegalovirus Test Positive, Dyspnoea, Gamma-glutamyltransferase Increased, Interstitial Lung Disease, Lung Disorder, Opportunistic Infection
on Dec 14, 2009 Female patient from JAPAN , weighting 94.80 lb, was diagnosed with thymoma, fungal infection (What is fungal infection?), osteoporosis (What is osteoporosis?), gastritis and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, body temperature increased, cytomegalovirus test positive, dyspnoea, gamma-glutamyltransferase increased, interstitial lung disease, lung disorder, opportunistic infection. Lamisil dosage: 125 Mg Daily. During the same period patient was treated with ENDOXAN (Unk) (View Endoxan Review and Endoxan Label ), PREDONINE (15 Df, Unk) (View Predonine Review and Predonine Label ), BAKTAR (4 Df, Unk) (View Baktar Review and Baktar Label ), BENET (17.5 Df, Unk) (View Benet Review and Benet Label ), GASLON (4 Df, Unk) (View Gaslon Review and Gaslon Label ), VISCORIN (3 G, Unk) (View Viscorin Review and Viscorin Label ). Patient was hospitalized.

6491210-0 | Platelet Count Increased
Patient was taking Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count increased on Nov 30, 2009 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with onychomycosis and. Lamisil dosage: 125 Mg.

6484449-1 | Pancytopenia
Adverse event was reported on Nov 30, 2009 by a Female patient taking Lamisil (View Usage) (Dosage: ) . Location: JAPAN , 80 years of age, Patient had the following side effects: pancytopenia.

6475513-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin, Gamma-glutamyltransferase, Hepatitis C, Hepatitis C Antibody Positive, Liver Disorder, Metastases To Liver
on Nov 30, 2009 Female patient from JAPAN , weighting 143.3 lb, was diagnosed with tinea infection (What is tinea infection?), hyperlipidaemia and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin, gamma-glutamyltransferase, hepatitis c (What is hepatitis c?), hepatitis c antibody positive, liver disorder, metastases to liver. Lamisil dosage: 125 Mg Per Day. During the same period patient was treated with LIPITOR (10 Mg) (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6462563-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Feeling Cold, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Tremor
on Nov 19, 2009 Male patient from JAPAN , 60 years of age, was diagnosed with tinea infection (What is tinea infection?), cardiac disorder and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, feeling cold, gamma-glutamyltransferase increased, hepatic function abnormal, tremor. Lamisil dosage: . During the same period patient was treated with BERAPROST SODIUM (View Beraprost Sodium Review and Beraprost Sodium Label ), ETHYL ICOSAPENTATE (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ).

6462091-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Feeling Cold, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Tremor
Patient was taking Lamisil (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, feeling cold, gamma-glutamyltransferase increased, hepatic function abnormal, tremor on Nov 19, 2009 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with tinea infection (What is tinea infection?), cardiac disorder and. Lamisil dosage: . During the same period patient was treated with BERAPROST SODIUM (View Beraprost Sodium Review and Beraprost Sodium Label ), ETHYL ICOSAPENTATE (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ).

6461902-8 | Diplopia
Adverse event was reported on Nov 24, 2009 by a Female patient taking Lamisil (View Usage) (Dosage: 250 Mg For 14 Days) . Location: BELGIUM , 45 years of age, After Lamisil was administered, patient had the following side effects: diplopia. During the same period patient was treated with VENLAFAXINE (150 Mg) (View Venlafaxine Review and Venlafaxine Label ).

6461890-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin, Gamma-glutamyltransferase, Hepatitis C Antibody Positive, Hepatitis Viral, Liver Disorder, Pancreatic Carcinoma
on Nov 20, 2009 Female patient from JAPAN , weighting 143.3 lb, was diagnosed with tinea infection (What is tinea infection?), hyperlipidaemia and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin, gamma-glutamyltransferase, hepatitis c antibody positive, hepatitis viral, liver disorder, pancreatic carcinoma. Lamisil dosage: Unk. During the same period patient was treated with LIPITOR (10 Mg) (View Lipitor Review and Lipitor Label ).

6454416-2 | C-reactive Protein Increased, Erythema, Erythema Multiforme, Pruritus, Rash, Rash Pustular
on Nov 11, 2009 Female patient from JAPAN , 70 years of age, weighting 105.8 lb, was diagnosed with hypertension and was treated with Lamisil (View Usage). Patient had the following side effects: c-reactive protein increased, erythema, erythema multiforme, pruritus, rash (What is rash?), rash pustular. Lamisil dosage: 125 Mg, Qd. During the same period patient was treated with DIOVAN (Unk) (View Diovan Review and Diovan Label ), AMLODIPINE (Unk) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6445215-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Feeling Cold, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Tremor
Patient was taking Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, feeling cold, gamma-glutamyltransferase increased, hepatic function abnormal, tremor on Nov 10, 2009 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with tinea infection (What is tinea infection?), cardiac disorder and. Lamisil dosage: . During the same period patient was treated with BERAPROST SODIUM (View Beraprost Sodium Review and Beraprost Sodium Label ), ETHYL ICOSAPENTATE (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ).

6444312-9 | Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Body Temperature Increased, Dyspnoea, Gamma-glutamyltransferase Increased, Interstitial Lung Disease, Lung Disorder, Opportunistic Infection
Adverse event was reported on Nov 06, 2009 by a Female patient taking Lamisil (View Usage) (Dosage: 125 Mg Daily) was diagnosed with thymoma, fungal infection (What is fungal infection?), osteoporosis (What is osteoporosis?), gastritis, oral candidiasis and. Location: JAPAN , weighting 94.80 lb, Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, body temperature increased, dyspnoea, gamma-glutamyltransferase increased, interstitial lung disease, lung disorder, opportunistic infection. During the same period patient was treated with ENDOXAN (Unk) (View Endoxan Review and Endoxan Label ), PREDONINE (15 Df, Unk) (View Predonine Review and Predonine Label ), BAKTAR (4 Df, Unk) (View Baktar Review and Baktar Label ), BENET (17.5 Df, Unk) (View Benet Review and Benet Label ), GASLON (4 Df, Unk) (View Gaslon Review and Gaslon Label ), VISCORIN (3 G, Unk) (View Viscorin Review and Viscorin Label ), MICONAZOLE NITRATE (10 G, Unk) (View Miconazole Nitrate Review and Miconazole Nitrate Label ). Patient was hospitalized.

6437102-4 | Interstitial Lung Disease
on Oct 30, 2009 Female patient from JAPAN , 56 years of age, was treated with Lamisil (View Usage). Patient had the following side effects: interstitial lung disease. Lamisil dosage: 125 Mg Daily. During the same period patient was treated with PREDONINE (Unk) (View Predonine Review and Predonine Label ), BAKTAR (Unk) (View Baktar Review and Baktar Label ), BENET (Unk) (View Benet Review and Benet Label ). Patient was hospitalized.

6433152-2 | Blood Creatine Phosphokinase Increased, Myalgia
on Oct 30, 2009 Male patient from JAPAN , 69 years of age, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: blood creatine phosphokinase increased, myalgia. Lamisil dosage: 125 Mg Daily. During the same period patient was treated with CRESTOR (Unk) (View Crestor Review and Crestor Label ). Patient was hospitalized.

6425729-5 | Caesarean Section, Normal Newborn
Patient was taking Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, normal newborn on Oct 30, 2009 from CHINA Additional patient health information: Female patient , 43 years of age, was diagnosed with onychomycosis and. Lamisil dosage: 250 Mg, Qd.

6424820-7 | Erysipelas
Adverse event was reported on Oct 27, 2009 by a Male patient taking Lamisil (View Usage) (Dosage: Unk) was diagnosed with onychomycosis, tinea pedis and. Location: BRAZIL , 61 years of age, weighting 180.8 lb, Patient had the following side effects: erysipelas.

6421594-0 | Arrhythmia, Blood Pressure Increased, Ventricular Extrasystoles
on Oct 13, 2009 Male patient from JAPAN , 65 years of age, was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), blood pressure increased, ventricular extrasystoles. Lamisil dosage: 125 Mg/day.

6418905-9 | Chromaturia, Constipation, Dyspnoea, Faeces Discoloured, Jaundice, Lethargy, Liver Disorder, Nausea, Pruritus
on Oct 28, 2009 Female patient from UNITED STATES , 50 years of age, weighting 165.0 lb, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: chromaturia, constipation (What is constipation?), dyspnoea, faeces discoloured, jaundice (What is jaundice?), lethargy, liver disorder, nausea (What is nausea?), pruritus. Lamisil dosage: 250mg One Daily.

6416512-5 | Diplopia
Patient was taking Lamisil (View Usage). Patient had the following side effects: diplopia on Oct 20, 2009 from BELGIUM Additional patient health information: Female patient , 45 years of age, . Lamisil dosage: 250 Mg For 14 Days. During the same period patient was treated with VENLAFAXINE (150 Mg) (View Venlafaxine Review and Venlafaxine Label ).